Adicet Bio, Inc.
ACET- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001720580
No open-market purchases or sales by Adicet Bio, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $52.8M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Adicet Bio, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 100
- 0 vs. Q3 2022
- Shares held
- 42.0M
- +646.1K (+1.6%) vs. Q3 2022
- Total value
- $375.7M
- −$212.6M (−36.1%) vs. Q3 2022
- New holders
- 24
- 31 more added
- Sold out
- 24
- 30 more reduced
2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACET on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 56 | $52.8M |
| Q1 2026 | 49 | $43.7M |
| Q4 2025 | 49 | $56.6M |
| Q3 2025 | 54 | $41.6M |
| Q2 2025 | 49 | $31.5M |
| Q1 2025 | 56 | $42.0M |
| Q4 2024 | 64 | $55.4M |
| Q3 2024 | 64 | $82.3M |
| Q2 2024 | 86 | $77.4M |
| Q1 2024 | 98 | $176.6M |
| Q4 2023 | 77 | $63.0M |
| Q3 2023 | 84 | $48.9M |
| Q2 2023 | 95 | $90.4M |
| Q1 2023 | 107 | $231.3M |
| Q4 2022 | 100 | $375.7M |
| Q3 2022 | 102 | $590.7M |
| Q2 2022 | 101 | $555.9M |
| Q1 2022 | 88 | $660.4M |
| Q4 2021 | 81 | $531.2M |
| Q3 2021 | 58 | $156.1M |
| Q2 2021 | 66 | $218.1M |
| Q1 2021 | 54 | $266.3M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Adicet Bio, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −2,059,372−100.0% | Sold out |
| Deep Track Capital, LP | 0 | $0 | 0.00% | −825,508−100.0% | Sold out |
| Sofinnova Investments, Inc. | 0 | $0 | 0.00% | −491,965−100.0% | Sold out |
| Ally Bridge Group (NY) LLC | 0 | $0 | 0.00% | −244,400−100.0% | Sold out |
| Altium Capital Management LP | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −124,379−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −112,355−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −109,389−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −84,548−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −57,094−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −35,478−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −33,500−100.0% | Sold out |
| BIT Capital GmbH | 0 | $0 | 0.00% | −28,052−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −21,883−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −19,821−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −15,454−100.0% | Sold out |
| Gyon Technologies Capital Management, LP | 0 | $0 | 0.00% | −14,924−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −14,374−100.0% | Sold out |
| Annandale Capital, LLC | 0 | $0 | 0.00% | −4,600−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −923−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −187−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −106−100.0% | Sold out |
| Crewe Advisors LLC | 0 | $0 | 0.00% | −175−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Foresite Capital Opportunity Management V, LLC | – | – | – | – | Not filed |
| American Portfolios Advisors | – | – | – | – | Not filed |